Skip to content

Performance, Safety and Efficacy of NPWT Device

NPWT Pre-registration Study: A Prospective, Multicentre Trial to Assess Performance, Safety and Efficacy of a Single-use NPWT Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04102865
Enrollment
90
Registered
2019-09-25
Start date
2019-07-12
Completion date
2022-07-27
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing and Prevention

Keywords

surgical complication, Negative-Pressure Wound Therapy (NPWT), negative pressure, knee arthroplasty, abdominal incision

Brief summary

Smith & Nephew are assessing a new investigational single use NPWT system.

Detailed description

Smith & Nephew are assessing a new investigational single use NPWT system. There is a significant amount of clinical evidence to show that NPWT may reduce oedema, increase healing and reduce chance of infection, through maintenance of pressure therapy, in closed incisions. Subjects with abdominal incisions and knee incisions following knee surgery will be recruited to the study and receive NPWT for 7 days. The performance of the system will be logged by the device and acceptability of the device will be assessed by patient and clinician. Safety will be assessed with a 30 day follow up to assess complications and device related events.

Interventions

DEVICENegative-Pressure Wound Therapy (NPWT)

Investigational single use disposable negative pressure system. The system is capable of delivering up to 80 mm Hg negative pressure to a wound or surgical incision site and managing low to moderate levels of exudate or fluid generated by the wound or incision. The therapy may be administered for up to 7 days.

Sponsors

Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The subject must provide written informed consent. * Subjects eighteen (18) years of age or older. * Willing and able to make all required study visits. * Able to follow instructions. * Subject is suitable to participate in the study in the opinion of the Investigator * In Orthopaedic surgery: subject is scheduled for an elective primary knee replacement arthroplasty and American Society of Anesthesiologists (ASA) score of 2-3 (Phase 1 only) * In Abdominal surgery: subject is scheduled for an elective open or laparoscopic gastrointestinal and/or gynaecological surgery with incision ≥5 cm and has an ASA score of 2-3. * Immediately after the surgery, subject will have one suitable closed abdominal or knee surgery incision (if there is more than one incision, then the clinician should choose the one which, in their opinion, is most suited for Negative Pressure Wound Therapy) that fits under the absorbent dressing area of the appropriate Negative Pressure dressing sizes .

Exclusion criteria

* Contraindications (per the Investigator Brochure) or hypersensitivity to the use of the investigational product or their components (e.g. silicone adhesives and polyurethane films \[direct contact with incision\], acrylic adhesives \[direct contact with skin\], polyethylene fabrics and super-absorbent powders \[polyacrylates\]) within the dressing). * Subjects with extremely fragile skin who require the use of SECURA™ non-sting barrier skin wipes and have hypersensitivity to the ingredients in the wipes * Participation in the treatment period of another similar clinical trial (wound care related) within thirty (30) days of operative visit or during the study. * Subjects with skin features (e.g. tattoos, skin colour, pre-existing scarring) which in the opinion of the Investigator, will interfere with the study assessments. * Subjects attending for an operation at the same surgery site (anatomical location) within the last 3 months * Subjects undergoing a procedure as part of palliative care (to be confirmed during surgery). * Subjects where the area of the device would be placed on a load-bearing anatomical location (i.e. areas vulnerable to pressure damage). * Subjects with incisions that are actively bleeding unless haemostasis has been achieved (to be confirmed during surgery). * Subjects with infected skin lesions or incisions at the time of surgery (any area of the body). * Subjects who have participated previously in this clinical trial * Subjects with a history of poor compliance with medical treatment. * Subjects with a BMI ≥ 40. * Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Negative Pressure Maintenance at Nominal 80 mmHg30 days post-opNegative pressure maintenance at nominal 80 mmHg assessed as the average of the negative pressure values recorded by the device for Abdominal and Knee surgery types. This data was summarized to show an average negative pressure provided over the treatment duration.
Dressing Wear Time7 daysDressing wear time in days as assessed of any unplanned dressing change by Abdominal and Knee surgery type.
Exudate Management (Occurrence of Exudate Leaks)7 daysNumber of participants with occurrence of exudate leaks. Leakage classified as 'Any Leak' (Yes/No) by Abdominal and Knee surgery type.

Secondary

MeasureTime frameDescription
Condition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline, 7 days, 14 days, and 30 daysCondition of skin under investigative single use Negative-Pressure Wound Therapy (NPWT) dressing assessed through visual inspection by the investigator at baseline, 7, 14, and 30 days. Number of participants by Abdominal and Knee surgery type where skin was categorized with any condition that applied (i.e., multiple selections possible) from the following criteria: * Healthy * Fragile * Inflamed * Erythema * Bruising * Eczematous * Dry and Flaky * Macerated * Other
Wound and Skin Visual Analog Scale (VAS) Score Assessment7 days, 14 days, and 30 daysWound and Skin VAS score assessment at 7, 14 and 30 days. Scores range from 0 to 100 with a low score associated to a wound with a major gapping, dehiscence, severe inflammation and/or infection (i.e., poor outcome); and a high correspond to a completely healed wound with no evidence for inflammation (i.e., excellent outcome).
Incidence of Surgical Site Infection (SSI)30 daysNumber of participants with incidence of Surgical Site Infection (SSI) within 30 days of surgery classified using Centers for Decease Control (CDC) criteria of: * Superficial Infection * Deep Infection * Organ Space Infection * Other
Level of Pain During Wear of the Investigational Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score4 days and 7 daysLevel of pain during wear by investigational single use Negative-Pressure Wound Therapy (NPWT) Dressing at day 4 and day 7 assessed using a Visual Analog Scale (VAS) from 0 to 100 where a score of 0 indicated no pain and 100 indicated maximum pain.
Level of Pain at Dressing Removal of the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score7 daysLevel of pain during dressing removal by Abdominal and Knee surgery type at treatment discontinuation (up to day 7) assessed using a Visual Analog Scale (VAS) from 0 to 100 where a score of 0 indicated no pain and 100 indicated maximum pain.
Range of Motion Assessment (ROM) for the Knee30 daysRange of Motion (ROM) assessment for the knee at pre-operative visit, post-operative visit, 7, 14 and 30 days.
Incidence of Surgical Site Complications (SSC)30 daysNumber of participants with incidence of Surgical Site Complications (SSC) within 30 days of surgery categorized as: * Deep Dehiscence * Superficial Dehiscence * Partial Dehiscence * Total Dehiscence * Seroma * Necrosis * Hematoma * Suture Abscess * Other
Condition of Peri-Wound Skin Assessed Through Visual InspectionBaseline, 7 days, 14 days, and 30 daysCondition of peri-wound skin assessed through visual inspection by the investigator at baseline, 7, 14, and 30 days. Number of participants by Abdominal and Knee surgery type where skin was categorized with any condition that applied (i.e., multiple selections possible) from the following criteria: * Healthy * Fragile * Inflamed * Erythema * Bruising * Eczematous * Dry and Flaky * Macerated * Other

Countries

United Kingdom

Participant flow

Recruitment details

Enrollment began 12 July 2019 to 01 February 2022 across 8 investigative sites.

Participants by arm

ArmCount
Abdominal
Abdominal surgery type with investigational single use NPWT dressing
68
Knee
Knee surgery type with investigational single use NPWT dressing
22
Total90

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event40
Overall StudyLost to Follow-up10
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicAbdominalKneeTotal
Age, Continuous66.9 years
STANDARD_DEVIATION 11.9
70.4 years
STANDARD_DEVIATION 7.6
67.8 years
STANDARD_DEVIATION 11.1
Body Mass Index (BMI)28.0 kg/m^2
STANDARD_DEVIATION 5.2
31.5 kg/m^2
STANDARD_DEVIATION 3.4
28.9 kg/m^2
STANDARD_DEVIATION 5
Race/Ethnicity, Customized
Ethnicity
Any Other White Background
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Ethnicity
Not Stated
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Ethnicity
White and Asian Mixed
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Ethnicity
White British
63 Participants22 Participants85 Participants
Race/Ethnicity, Customized
Ethnicity
White Irish
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race
Asian
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race
Caucasian
67 Participants22 Participants89 Participants
Region of Enrollment
United Kingdom
68 participants22 participants90 participants
Sex: Female, Male
Female
26 Participants14 Participants40 Participants
Sex: Female, Male
Male
42 Participants8 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 680 / 22
other
Total, other adverse events
45 / 6819 / 22
serious
Total, serious adverse events
19 / 681 / 22

Outcome results

Primary

Dressing Wear Time

Dressing wear time in days as assessed of any unplanned dressing change by Abdominal and Knee surgery type.

Time frame: 7 days

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the surgery type specified.

ArmMeasureValue (MEAN)Dispersion
AbdominalDressing Wear Time5.7 daysStandard Deviation 2.4
KneeDressing Wear Time5.3 daysStandard Deviation 2.1
Primary

Exudate Management (Occurrence of Exudate Leaks)

Number of participants with occurrence of exudate leaks. Leakage classified as 'Any Leak' (Yes/No) by Abdominal and Knee surgery type.

Time frame: 7 days

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the surgery type specified.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
AbdominalExudate Management (Occurrence of Exudate Leaks)Any Leak: Yes5 Participants
AbdominalExudate Management (Occurrence of Exudate Leaks)Any Leak: No63 Participants
KneeExudate Management (Occurrence of Exudate Leaks)Any Leak: Yes12 Participants
KneeExudate Management (Occurrence of Exudate Leaks)Any Leak: No10 Participants
Primary

Negative Pressure Maintenance at Nominal 80 mmHg

Negative pressure maintenance at nominal 80 mmHg assessed as the average of the negative pressure values recorded by the device for Abdominal and Knee surgery types. This data was summarized to show an average negative pressure provided over the treatment duration.

Time frame: 30 days post-op

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the surgery type specified.

ArmMeasureValue (MEAN)Dispersion
AbdominalNegative Pressure Maintenance at Nominal 80 mmHg-71.5 millimeters of mercury (mmHg)Standard Deviation 25.1
KneeNegative Pressure Maintenance at Nominal 80 mmHg-56.0 millimeters of mercury (mmHg)Standard Deviation 28.2
Secondary

Condition of Peri-Wound Skin Assessed Through Visual Inspection

Condition of peri-wound skin assessed through visual inspection by the investigator at baseline, 7, 14, and 30 days. Number of participants by Abdominal and Knee surgery type where skin was categorized with any condition that applied (i.e., multiple selections possible) from the following criteria: * Healthy * Fragile * Inflamed * Erythema * Bruising * Eczematous * Dry and Flaky * Macerated * Other

Time frame: Baseline, 7 days, 14 days, and 30 days

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the specified assessment at the time point indicated. Because multiple responses were possible, Healthy skin could be recorded along with any other conditions. Where this occurred, the investigator believed the other condition(s) selected did not affect the healthiness of the skin.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Healthy59 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Eczematous0 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Fragile2 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Fragile1 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Inflamed7 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Erythema2 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Erythema9 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Inflamed4 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Bruising17 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Dry and Flaky0 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Eczematous2 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Erythema2 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Dry and Flaky5 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Inflamed2 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Macerated1 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Bruising35 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Other6 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Macerated0 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Healthy59 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Eczematous1 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Fragile4 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Bruising0 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Inflamed3 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Dry and Flaky3 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Erythema3 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Other1 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Bruising0 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Macerated1 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Eczematous1 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Fragile4 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Dry and Flaky9 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Other4 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Macerated0 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Healthy59 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Other4 Participants
AbdominalCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Healthy68 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Other2 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Healthy22 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Fragile0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Inflamed0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Erythema0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Bruising1 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Eczematous0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Dry and Flaky0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Macerated0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual InspectionBaseline: Other0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Healthy19 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Fragile0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Inflamed2 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Erythema1 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Bruising12 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Eczematous0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Dry and Flaky1 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Macerated0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection7 Days: Other3 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Healthy21 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Fragile0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Inflamed3 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Erythema2 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Bruising5 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Eczematous0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Dry and Flaky0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Macerated0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection14 Days: Other3 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Healthy22 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Fragile0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Inflamed1 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Erythema0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Bruising2 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Eczematous0 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Dry and Flaky4 Participants
KneeCondition of Peri-Wound Skin Assessed Through Visual Inspection30 Days: Macerated0 Participants
Secondary

Condition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection

Condition of skin under investigative single use Negative-Pressure Wound Therapy (NPWT) dressing assessed through visual inspection by the investigator at baseline, 7, 14, and 30 days. Number of participants by Abdominal and Knee surgery type where skin was categorized with any condition that applied (i.e., multiple selections possible) from the following criteria: * Healthy * Fragile * Inflamed * Erythema * Bruising * Eczematous * Dry and Flaky * Macerated * Other

Time frame: Baseline, 7 days, 14 days, and 30 days

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the specified assessment at the time point indicated. Because multiple responses were possible, Healthy skin could be recorded along with any other conditions. Where this occurred, the investigator believed the other condition(s) selected did not affect the healthiness of the skin.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Healthy64 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Eczematous0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Fragile2 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Fragile0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Inflamed1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Erythema0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Erythema1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Inflamed1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Bruising6 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Dry and Flaky0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Eczematous1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Erythema1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Dry and Flaky1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Inflamed0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Macerated0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Bruising10 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Other2 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Macerated0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Healthy60 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Eczematous0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Fragile1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Bruising13 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Inflamed1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Dry and Flaky1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Erythema3 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Other0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Bruising0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Macerated0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Eczematous1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Fragile1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Dry and Flaky3 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Other3 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Macerated0 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Healthy62 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Other1 Participants
AbdominalCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Healthy68 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Other0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Healthy22 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Fragile0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Inflamed0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Erythema0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Bruising0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Eczematous0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Dry and Flaky0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Macerated0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual InspectionBaseline: Other0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Healthy19 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Fragile0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Inflamed0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Erythema0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Bruising3 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Eczematous0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Dry and Flaky0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Macerated0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection7 Days: Other3 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Healthy21 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Fragile0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Inflamed1 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Erythema0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Bruising0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Eczematous0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Dry and Flaky1 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Macerated0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection14 Days: Other0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Healthy21 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Fragile0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Inflamed0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Erythema0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Bruising0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Eczematous0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Dry and Flaky0 Participants
KneeCondition of Skin Under the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed Through Visual Inspection30 Days: Macerated0 Participants
Secondary

Incidence of Surgical Site Complications (SSC)

Number of participants with incidence of Surgical Site Complications (SSC) within 30 days of surgery categorized as: * Deep Dehiscence * Superficial Dehiscence * Partial Dehiscence * Total Dehiscence * Seroma * Necrosis * Hematoma * Suture Abscess * Other

Time frame: 30 days

Population: Full Analysis Set (FAS) population included all enrolled participants with available data for the specified assessment. Out of 90 (68 Abdominal, 22 Knee) participants overall, 10 (9 Abdominal, 1 Knee) participants experienced at least one Surgical Site Complication (SSC) indicated by the given criteria.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
AbdominalIncidence of Surgical Site Complications (SSC)Suture Abscess0 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Deep Dehiscence2 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Haematoma2 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Superficial Dehiscence6 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Other2 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Partial Dehiscence5 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Total Dehiscence1 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Necrosis0 Participants
AbdominalIncidence of Surgical Site Complications (SSC)Seroma0 Participants
KneeIncidence of Surgical Site Complications (SSC)Partial Dehiscence0 Participants
KneeIncidence of Surgical Site Complications (SSC)Necrosis0 Participants
KneeIncidence of Surgical Site Complications (SSC)Haematoma0 Participants
KneeIncidence of Surgical Site Complications (SSC)Suture Abscess0 Participants
KneeIncidence of Surgical Site Complications (SSC)Other1 Participants
KneeIncidence of Surgical Site Complications (SSC)Seroma0 Participants
KneeIncidence of Surgical Site Complications (SSC)Deep Dehiscence0 Participants
KneeIncidence of Surgical Site Complications (SSC)Superficial Dehiscence0 Participants
KneeIncidence of Surgical Site Complications (SSC)Total Dehiscence0 Participants
Secondary

Incidence of Surgical Site Infection (SSI)

Number of participants with incidence of Surgical Site Infection (SSI) within 30 days of surgery classified using Centers for Decease Control (CDC) criteria of: * Superficial Infection * Deep Infection * Organ Space Infection * Other

Time frame: 30 days

Population: Full Analysis Set (FAS) population included all enrolled participants with available data for the specified assessment. Out of 90 (68 Abdominal, 22 Knee) participants overall, 5 (5 Abdominal, 0 Knee) participants experienced at least one Surgical Site Infection (SSI) indicated by the given criteria.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
AbdominalIncidence of Surgical Site Infection (SSI)Superficial Infection3 Participants
AbdominalIncidence of Surgical Site Infection (SSI)Deep Infection2 Participants
AbdominalIncidence of Surgical Site Infection (SSI)Organ Space Infection1 Participants
AbdominalIncidence of Surgical Site Infection (SSI)Other1 Participants
KneeIncidence of Surgical Site Infection (SSI)Other0 Participants
KneeIncidence of Surgical Site Infection (SSI)Superficial Infection0 Participants
KneeIncidence of Surgical Site Infection (SSI)Organ Space Infection0 Participants
KneeIncidence of Surgical Site Infection (SSI)Deep Infection0 Participants
Secondary

Level of Pain at Dressing Removal of the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score

Level of pain during dressing removal by Abdominal and Knee surgery type at treatment discontinuation (up to day 7) assessed using a Visual Analog Scale (VAS) from 0 to 100 where a score of 0 indicated no pain and 100 indicated maximum pain.

Time frame: 7 days

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the specified assessment at the time point indicated.

ArmMeasureValue (MEAN)Dispersion
AbdominalLevel of Pain at Dressing Removal of the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score12.6 score on a scaleStandard Deviation 18.3
KneeLevel of Pain at Dressing Removal of the Investigative Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score31.6 score on a scaleStandard Deviation 30.7
Secondary

Level of Pain During Wear of the Investigational Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score

Level of pain during wear by investigational single use Negative-Pressure Wound Therapy (NPWT) Dressing at day 4 and day 7 assessed using a Visual Analog Scale (VAS) from 0 to 100 where a score of 0 indicated no pain and 100 indicated maximum pain.

Time frame: 4 days and 7 days

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the specified assessment at the time point indicated.

ArmMeasureGroupValue (MEAN)Dispersion
AbdominalLevel of Pain During Wear of the Investigational Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score4 Days20.2 score on a scaleStandard Deviation 24.7
AbdominalLevel of Pain During Wear of the Investigational Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score7 Days14.2 score on a scaleStandard Deviation 20.5
KneeLevel of Pain During Wear of the Investigational Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score4 Days41.8 score on a scaleStandard Deviation 28.8
KneeLevel of Pain During Wear of the Investigational Single Use Negative-Pressure Wound Therapy (NPWT) Dressing Assessed by VAS Score7 Days35.4 score on a scaleStandard Deviation 26
Secondary

Range of Motion Assessment (ROM) for the Knee

Range of Motion (ROM) assessment for the knee at pre-operative visit, post-operative visit, 7, 14 and 30 days.

Time frame: 30 days

Population: Data reported for knee extension in Knee Group interpreted as negative (extension deficit) or positive (actual extension). Therefore, ROM can be the sum or difference of reported knee flexion \& extension. Because different Investigators applied different interpretations, there is low confidence in reliability of ROM data. Further investigation is required with additional clinical evaluations before the investigational NPWT device can be considered suitable for consideration in TKA subjects.

ArmMeasureGroupValue (MEAN)Dispersion
AbdominalRange of Motion Assessment (ROM) for the KneePre-Operative - Flexion102.5 degreesStandard Deviation 17.2
AbdominalRange of Motion Assessment (ROM) for the KneePre-Operative - Extension Angle9.4 degreesStandard Deviation 7.7
AbdominalRange of Motion Assessment (ROM) for the KneePre-Operative - ROM93.1 degreesStandard Deviation 20.7
AbdominalRange of Motion Assessment (ROM) for the KneePost-Operative - Flexion61.6 degreesStandard Deviation 20.3
AbdominalRange of Motion Assessment (ROM) for the KneePost-Operative - Extension Angle6.6 degreesStandard Deviation 5.9
AbdominalRange of Motion Assessment (ROM) for the KneePost-Operative - ROM54.9 degreesStandard Deviation 21.6
AbdominalRange of Motion Assessment (ROM) for the KneeDay 7 (Pre-Dressing Removal) - Flexion75.5 degreesStandard Deviation 16.1
AbdominalRange of Motion Assessment (ROM) for the KneeDay 7 (Pre-Dressing Removal) - Extension Angle14.2 degreesStandard Deviation 9.5
AbdominalRange of Motion Assessment (ROM) for the KneeDay 7 (Pre-Dressing Removal) - ROM61.6 degreesStandard Deviation 16.6
AbdominalRange of Motion Assessment (ROM) for the KneeDay 7 (Post-Dressing Removal) - Flexion75.6 degreesStandard Deviation 19.7
AbdominalRange of Motion Assessment (ROM) for the KneeDay 7 (Post-Dressing Removal) - Extension Angle11.2 degreesStandard Deviation 6.9
AbdominalRange of Motion Assessment (ROM) for the KneeDay 7 (Post-Dressing Removal) - ROM64.4 degreesStandard Deviation 18.2
AbdominalRange of Motion Assessment (ROM) for the KneeDay 14 - Flexion86.3 degreesStandard Deviation 17.2
AbdominalRange of Motion Assessment (ROM) for the KneeDay 14 - Extension Angle10.2 degreesStandard Deviation 6.3
AbdominalRange of Motion Assessment (ROM) for the KneeDay 14 - ROM76.0 degreesStandard Deviation 18.1
AbdominalRange of Motion Assessment (ROM) for the KneeDay 30 - Flexion100.4 degreesStandard Deviation 15.8
AbdominalRange of Motion Assessment (ROM) for the KneeDay 30 - Extension Angle8.7 degreesStandard Deviation 5.6
AbdominalRange of Motion Assessment (ROM) for the KneeDay 30 - ROM91.6 degreesStandard Deviation 15.9
Secondary

Wound and Skin Visual Analog Scale (VAS) Score Assessment

Wound and Skin VAS score assessment at 7, 14 and 30 days. Scores range from 0 to 100 with a low score associated to a wound with a major gapping, dehiscence, severe inflammation and/or infection (i.e., poor outcome); and a high correspond to a completely healed wound with no evidence for inflammation (i.e., excellent outcome).

Time frame: 7 days, 14 days, and 30 days

Population: Full Analysis Set (FAS) population included enrolled participants with available data for the specified assessment at the time point indicated.

ArmMeasureGroupValue (MEAN)Dispersion
AbdominalWound and Skin Visual Analog Scale (VAS) Score Assessment7 Days79.0 score on a scaleStandard Deviation 26.7
AbdominalWound and Skin Visual Analog Scale (VAS) Score Assessment14 Days81.4 score on a scaleStandard Deviation 26.1
AbdominalWound and Skin Visual Analog Scale (VAS) Score Assessment30 Days85.0 score on a scaleStandard Deviation 27.6
KneeWound and Skin Visual Analog Scale (VAS) Score Assessment7 Days89.9 score on a scaleStandard Deviation 7.4
KneeWound and Skin Visual Analog Scale (VAS) Score Assessment14 Days89.4 score on a scaleStandard Deviation 10.4
KneeWound and Skin Visual Analog Scale (VAS) Score Assessment30 Days95.0 score on a scaleStandard Deviation 5.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026